Table 2 Distributions of clinical, biological and imaging parameters according to the outcome
|  | CMU N = 112 | ICU OR death N = 90 | P-value |
|---|---|---|---|
Anthropometry | |||
Age, years (IQR) | 71 (56–81) | 71 (63–80) | 0.31 |
Male, n (%) | 63 (56) | 64 (71) | 0.04 |
BMI (kg/m2) | 25 (22–29) | 26 (23–29) | 0.63 |
Cardiometabolic risk profile | |||
Active smoking, n (%) | 7 (6) | 7 (8) | 0.78 |
Hypertension, n (%) | 67 (60) | 59 (66) | 0.47 |
Dyslipidemia, n (%) | 38 (34) | 49 (54) | 0.003 |
CVDs, n (%) | 25 (22) | 24 (27) | 0.51 |
Adipose tissue imaging biomarkers | |||
CATi (mL/m2) | 102 (66–145) | 116 (70–157) | 0.12 |
VATi (mL/m2) | 506 (291–801) | 605 (357–931) | 0.26 |
SATi (mL/m2) | 423 (299–640) | 452 (255–621) | 0.79 |
CATi/VATi | 0.17 (0.12–0.25) | 0.18 (0.13–0.24) | 0.76 |
Lung CT severity score | |||
Minimal (10%) | 19 (17) | 13 (14) | 0.06 |
Moderate (10–25%) | 45 (40) | 22 (24) | |
Extensive (25–50%) | 35 (31) | 39 (43) | |
Severe (> 50%) | 13 (12) | 16 (18) | 0.23 |
Minimal (10%) vs > 10% | 19 (17) | 13 (14) | 0.70 |
Severe (> 50%) vs ≤ 50% | 13 (12) | 16 (18) | 0.23 |
CAC-DRS Classification | |||
0 | 29 (26) | 17 (19) | 0.14 |
1 | 49 (44) | 32 (36) | |
2 | 17 (15) | 24 (27) | |
3 | 17 (15) | 17 (19) | |
 > 0 | 29 (26) | 17 (19) | 0.31 |
3 vs < 3 | 17 (15) | 17 (19) | 0.57 |
Biological markers | |||
Leukocytes (× 109/L) | 6 (4.4–7.3) | 6.8 (5.6–8.9) | 0.005 |
Lymphocytes (× 109/L) | 1 (0.7–1.3) | 0.8 (0.7–1.2) | 0.08 |
Platelets (× 109/L) | 215 (160–261) | 206 (146–273) | 0.38 |
eGFR (mL/min/1.73 m2) | 86 (61–116) | 80 (59–100) | 0.46 |
CRP (mg/L) | 60 (29–105) | 93 (31–143) | 0.03 |
Troponin-T (ng/L) | 15 (8–30) | 23 (12–46) | 0.0007 |